Microbial Pattern and Antibiotic Resistance of Severe Pneumonia in A National Referral Hospital in Indonesia

Keyphrases

• Acinetobacter Baumannii (A. baumannii) 33%
• American Thoracic Society 33%
• Amikacin 66%
• Ampicillin-sulbactam 66%
• Antibiotic Resistance 100%
• Antibiotic Susceptibility 33%
• Antibiotic Use 33%
• Bronchoalveolar Lavage 33%
• Bronchoscopy 66%
• Cerebrovascular Disease 33%
• Combined Therapy 33%
• Community-acquired Pneumonia 66%
• Comorbidity 33%
• COVID-19 33%
• Disc Diffusion 33%
• Empirical Therapy 33%
• Healthcare Facilities 33%
• High Risk 33%
• High Susceptibility 33%
• Indonesia 100%
• Indonesian 33%
• Infectious Diseases Society of America 33%
• Informed Consent 33%
• Intensive Care Unit 33%
• Isolated Microorganisms 33%
• Late-onset 33%
• Microbial Patterns 100%
• Microbial Resistance 33%
• Most Common Form 33%
• Neurologic 33%
• Nosocomial Infection 33%
• Patient Data 33%
• Pneumonia 66%
• Pneumonia Patients 66%
• Poor Adherence 33%
• Referral Hospital 100%
• Respiratory Infection 33%
• Respiratory Specimens 33%
• Severe Community-acquired Pneumonia 33%
• Severe Pneumonia 100%
• Susceptibility to Infection 33%
• Tertiary Care Hospital 33%
• Thioglycolate 33%
• Ventilator-associated Pneumonia 33%

Medicine and Dentistry

• Acinetobacter Baumannii 33%
• Amikacin 66%
• Ampicillin/Sulbactam 66%
• Antibiogram 33%
• Antibiotic Resistance 100%
• Antibiotics 33%
• Bronchoscopy 66%
• Cerebrovascular Disease 33%
• Combined Therapy 33%
• Community-Acquired Pneumonia 66%
• Comorbidity 33%
• Coronavirinae 33%
• COVID-19 33%
• Diseases 33%
• Hospital Infection 33%
• Hospital-Acquired Pneumonia 33%
• Infection 66%
• Informed Consent 33%
• Intensive Care Unit 33%
• Lung Lavage 33%
• Patient Referral 100%
• Patient-Data 33%
• Respiratory Tract Infection 33%
• Retrospective Study 33%
• Tertiary Care 33%
• Thioglycolic Acid 33%
• Ventilator-Associated Pneumonia 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acinetobacter Baumannii 25%
• Amikacin 50%
• Antibiotics 25%
• Antimicrobial Resistance 100%
• Cerebrovascular Disease 25%
• Community Acquired Pneumonia 50%
• Comorbidity 25%
• Coronavirinae 25%
• Diseases 25%
• Hospital Acquired Pneumonia 25%
• Hospital Infection 25%
• Infection 50%
• Microorganism 25%
• Respiratory Tract Infection 25%
• Retrospective Study 25%
• Sultamicillin 50%
• Thioglycolic Acid 25%
• Ventilator Associated Pneumonia 25%